首页> 外文期刊>Powder diffraction >Powder X-ray diffraction structural characterization of the coordination complex cis-[Co(k~2N,N'-1 ,10-phenanthroline-5,6-dione)_2CI_2]
【24h】

Powder X-ray diffraction structural characterization of the coordination complex cis-[Co(k~2N,N'-1 ,10-phenanthroline-5,6-dione)_2CI_2]

机译:配位配合物顺式[Co(k〜2N,N'-1,10-菲咯啉-5,6-二酮)_2CI_2]的粉末X射线衍射结构表征

获取原文
获取原文并翻译 | 示例
           

摘要

The reduction of cis-[Co-III(kappa N-2,N'-1.10-phenanthroline-5,6-dione)(2)Cl-2]Cl into the neutral compound cis-[Co-II(kappa N-2,N'-1,10-phenanthroline-5,6-dione)(2)Cl-2] was observed during developmental studies of new antimalarial drugs. The crystal structure of cis-[Co-II(kappa N-2,N'-1,10-phenanthroline-5,6-dione)(2)Cl-2] was unveiled by powder X-ray diffraction studies (PXRD). PXRD details, unit cell parameters, and space group for cis-[Co-II(kappa N-2,N'-1.10-phenanthroline-5,6-dione)(2) Cl-2], C24H12Cl2CoN4O4, are reported [a = 41.4951 (13) angstrom, b = 8.2768 (2) angstrom, c = 12.4994 (3) angstrom, unit cell volume V = 4292.9 (2) angstrom(3), Z = 8, and space group Fdd2]. Infrared spectroscopy features are also discussed. (C) 2018 International Centre for Diffraction Data.
机译:顺式-[Co-III(κN-2,N'-1.10-菲咯啉-5,6-二酮)(2)Cl-2] Cl还原为中性化合物顺式-[Co-II(kappa N- 2,N'-1,10-菲咯啉-5,6-二酮)(2)Cl-2]在新抗疟药的开发研究中被观察到。通过粉末X射线衍射研究(PXRD)揭示了顺式[Co-II(κN-2,N'-1,10-菲咯啉-5,6-二酮)(2)Cl-2]的晶体结构。报告了C24H12Cl2CoN4O4的顺式[Co-II(κN-2,N'-1.10-菲咯啉-5,6-二酮)(2)Cl-2]的PXRD详细信息,晶胞参数和空间群[a] = 41.4951(13)埃,b = 8.2768(2)埃,c = 12.4994(3)埃,晶胞体积V = 4292.9(2)埃(3),Z = 8,空间群Fdd2]。还讨论了红外光谱特征。 (C)2018年国际衍射数据中心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号